Editorial policy

Useful explanations, clear limits

Our publisher is Petros IT Solutions SRL, the company behind Dose & Lose. Our guides explain how GLP-1 medications work and what people commonly experience on them. They are educational and are not personal medical advice. They never tell a reader what dose to take, when to change it, or whether to start or stop a medication: those are decisions for the reader and their prescriber. App links promote our own product; store pricing and subscription terms apply.

Sources and verification

We rely on primary sources: each medication's prescribing information and patient leaflet, the regulators that approve them (such as the US FDA and the European Medicines Agency, and national agencies in each language we publish), clinical practice guidelines, and peer-reviewed clinical trials. Where a figure depends on the country, such as approval, availability or pricing, we say which country it applies to. Worked examples are checked arithmetically, and hypothetical values are labelled as illustrative, never presented as measurements. Publication and update dates appear on every guide.

Safety

Every guide that discusses symptoms says when to contact a doctor, and every guide ends with the same safety note. We describe side effects in the proportions the labels and trials report, without playing them down or dramatising them. We do not cover how to obtain medication without a prescription.

Authorship and checks

Our editorial team chooses every topic. Each guide is researched from the sources it cites and published once it passes our checks. Guides are signed by the Dose & Lose Editorial Team. The team and the publishing organization are responsible for the published text, and the team's page states what it does and does not claim.

Before publication, a separate check compares every figure with the source it cites, every statement about the app with our list of verified product facts, and every link with the page it points to. A guide that fails a check is not published. We do not invent experiences, professional qualifications, expert reviews, or results for the app. The pictures in our guides are illustrations, never evidence of a result.

Twelve languages

Each guide is published in English, Spanish, French, German, Dutch, Danish, Swedish, Russian, Portuguese, Italian, Turkish and Polish. Every version is written for its readers from the same sources and passes the same checks in its own language, so the figures, the worked examples and the structure match across all twelve. Where rules or approvals differ by country, each version names its readers' own regulator first. Portuguese follows Brazilian usage, and Spanish is written for readers in Spain and Latin America. A change to any version is checked again, in every language, before it goes live.

Corrections

Send corrections and supporting sources to office@doseandlose.com. Material corrections receive an updated date and an explanation in the guide.